Invasive infections due to Clavispora lusitaniae.
Three cases of Clavispora lusitaniae invasive fungal infections are reported. All three infections appeared in cancer patients presented with fungaemia, one additionally with meningitis. Two of them were breakthrough -- they developed during therapy with conventional amphotericin B with a dose of 0.5 mg kg(-1) day(-1) . All three were cured: two with intravenous fluconazol and one with an increasing dose (1 mg kg(-1) day(-1)) of amphotericin B. In one of two breakthrough cases the sensitivity of the strain to antifungals was tested against antifungal agents and showed in vitro resistance to amphotericin B (MIC 2 eta g ml(-1)).
Krcmery
V
V
University of Trnava, School of Public Health and Postgraduate Medical School, Slovak Republic.
Mateicka
F
F
Grausova
S
S
Kunova
A
A
Hanzen
J
J
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002675:Child, Preschool; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016921:Meningitis, Fungal / Q000188:drug therapy / Q000382:microbiology*; D009369:Neoplasms / Q000150:complications; D004718:Saccharomycetales / Q000302:isolation & purification*
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole